Filter by: Subject

Filter by: Subject

Results Per Page:

Atherosclerotic cardiovascular diseases (1)
Atherosclerotic plaque (1)
Benign vs. malignant (1)
Bone scan (1)
Cardiac implantable electronic device (CIED) (1)
Cardiovascular disorders (1)
Clinically significant prostate cancer (csPCa) (1)
Computed tomography (1)
Coronavirus disease 2019 (COVID-19) (1)
COVID-19 pandemic (1)
End-of-treatment (1)
FAPI tumor volume (FAPI-TV) (1)
Fibroblast activation protein (FAP) (1)
Fibroblast activation protein inhibitor (FAPI) (1)
Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG PET/CT) (1)
Fluorodeoxyglucose (FDG) (1)
Fluorodeoxyglucose positron emission tomography (FDG PET) (1)
Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) (1)
Gallium-68 pentixafor positron emission tomography/computed tomography ([68Ga]Ga-pentixafor PET/CT) (1)
Gynecological malignancies (1)
Hodgkin lymphoma (1)
Hypoxia inducible factor-1 (HIF-1) (1)
Hypoxia-inducible factor-1alpha (HIF-1) (1)
Hypoxic tumor volume (HTV) (1)
Immunosuppression (1)
Infective endocarditis (1)
Invasive fungal disease (IFD) (1)
Left ventricular assist device (1)
Logistic binomial regression (1)
Malignant melanoma (1)
Metabolic tumor volume (MTV) (1)
Metastatic hormone-sensitive prostate carcinoma (mHSPC) (1)
Myocarditis (1)
People living with human immunodeficiency virus (PLHIV) (1)
Principal component analysis (PCA) (1)
Prognosis (1)
Prostate specific antigen (PSA) (1)
Prosthetic valve (1)
Pulmonary tuberculosis (1)
Radiolabeled leucocyte scan (1)